# Inhibition of SENP1 for the Suppression of OS Growth and Metastasis

> **NCT03798587** · — · UNKNOWN · sponsor: **I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio** · enrollment: 15 (estimated)

## Conditions studied

- Primary Osteosarcoma of Bone

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03798587
- **Lead sponsor:** I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01
- **Primary completion:** 2020-12
- **Final completion:** 2021-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03798587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03798587, "Inhibition of SENP1 for the Suppression of OS Growth and Metastasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03798587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*